Asad Ali
Asad Ali has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Aditya Borakati
Royal Free London NHS Foundation Trust, London, UK
1 shared publication Alex Shearman
Royal Natl Orthopaed Hosp, Dept Trauma & Orthopaed, Stanmore, England
1 shared publication- Chetana Nagaraj
North Middlesex University Hospital
1 shared publication - Iftikhar Ahmed
Residents Cardiology Armed Forces Institute of Cardiology National Institute of Heart Diseases Rawalpindi Pakistan
1 shared publication John Skinner
Royal Natl Orthopaed Hosp, Dept Trauma & Orthopaed, Stanmore, England
1 shared publication- Michael Kurer
North Middlesex University Hospital
1 shared publication
Latest Publications
- 19 January 2024
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 39 (7) , 1811-1819
Survival Rates and Patient-Reported Outcomes Support the Use of Custom Cement-Over Megaprosthesis (CCOM) in Complex Revision Lower Limb Arthroplasty
- 19 January 2024
- Published by Elsevier in The Journal of Arthroplasty
- Vol. 39 (7) , 1811-1819
Survival Rates and Patient-Reported Outcomes Support the Use of Custom Cement-Over Megaprosthesis (CCOM) in Complex Revision Lower Limb Arthroplasty
- Open Access
Day case versus inpatient total shoulder arthroplasty: A retrospective cohort study and cost-effectiveness analysis
Background: Day case total shoulder arthroplasty (TSA) is a novel approach, not widely practiced in Europe. We conducted a retrospective cohort study of patients comparing elective day case and inpatient TSAs in our UK centre. Aim: To evaluate the efficacy and cost-effectiveness of day case total shoulder arthroplasty (TSA) compared to standard inpatient total shoulder arthroplasty. Methods: All patients undergoing TSA between January 2017 and July 2018 were included. Outcome measures were: change in abduction and extension 3 months postoperatively; 30 day postoperative adverse events and re-admissions in day case and inpatient groups. We also conducted an economic evaluation of outpatient arthroplasty. Multivariate linear and logistic regression were used to adjust for demographic and operative covariates. Results: 59 patients were included, 18 day cases and 41 inpatients. There were no adverse events or re-admissions at 30 days postoperatively in either group. There were no significant differences in adjusted flexion (mean difference 16.4°; 95% CI -17.6° to 50.5°, p=0.337) or abduction (mean difference 13.2° 95% CI; -18.4° to 44.9°, p=0.405) postoperatively between groups. Median savings with outpatient arthroplasty were GBP 529 (IQR 247.33 to 789, p<0.0001). Conclusion: Day case TSA is a safe, effective procedure, with significant cost benefit. Wider use may be warranted in the UK and beyond, with potential for significant cost savings and improved efficiency. Core tip: In this article we show that day case total shoulder arthroplasty is a feasible, safe and effective alternative to inpatient admission for the same procedure, with an associated average cost saving of GBP 529.
Open AccessDay case versus inpatient total shoulder arthroplasty: A retrospective cohort study and cost-effectiveness analysis
Background: Day case total shoulder arthroplasty (TSA) is a novel approach, not widely practiced in Europe. We conducted a retrospective cohort study of patients comparing elective day case and inpatient TSAs in our UK centre. Aim: To evaluate the efficacy and cost-effectiveness of day case total shoulder arthroplasty (TSA) compared to standard inpatient total shoulder arthroplasty. Methods: All patients undergoing TSA between January 2017 and July 2018 were included. Outcome measures were: change in abduction and extension 3 months postoperatively; 30 day postoperative adverse events and re-admissions in day case and inpatient groups. We also conducted an economic evaluation of outpatient arthroplasty. Multivariate linear and logistic regression were used to adjust for demographic and operative covariates. Results: 59 patients were included, 18 day cases and 41 inpatients. There were no adverse events or re-admissions at 30 days postoperatively in either group. There were no significant differences in adjusted flexion (mean difference 16.4°; 95% CI -17.6° to 50.5°, p=0.337) or abduction (mean difference 13.2° 95% CI; -18.4° to 44.9°, p=0.405) postoperatively between groups. Median savings with outpatient arthroplasty were GBP 529 (IQR 247.33 to 789, p<0.0001). Conclusion: Day case TSA is a safe, effective procedure, with significant cost benefit. Wider use may be warranted in the UK and beyond, with potential for significant cost savings and improved efficiency. Core tip: In this article we show that day case total shoulder arthroplasty is a feasible, safe and effective alternative to inpatient admission for the same procedure, with an associated average cost saving of GBP 529.